Ryo Fukuda

5.5k total citations · 3 hit papers
95 papers, 4.5k citations indexed

About

Ryo Fukuda is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ryo Fukuda has authored 95 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 28 papers in Hepatology and 14 papers in Surgery. Recurrent topics in Ryo Fukuda's work include Hepatitis C virus research (23 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (18 papers). Ryo Fukuda is often cited by papers focused on Hepatitis C virus research (23 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (18 papers). Ryo Fukuda collaborates with scholars based in Japan, United States and France. Ryo Fukuda's co-authors include Gregg L. Semenza, Huafeng Zhang, Chi V. Dang, Jung‐whan Kim, Larissa A. Shimoda, Fan Fan, Lee M. Ellis, Young Do Jung, Kiichi Hirota and Shunji Ishihara and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Ryo Fukuda

91 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells

2007 967 citations Ryo Fukuda, Huafeng Zhang et al. Cell profile →
HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity

2007 724 citations Huafeng Zhang, Ryo Fukuda et al. profile →
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells

2002 684 citations Ryo Fukuda, Gregg L. Semenza et al. profile →

Peers

Countries citing papers authored by Ryo Fukuda

Since Specialization

Citations

This map shows the geographic impact of Ryo Fukuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Fukuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Fukuda more than expected).

Fields of papers citing papers by Ryo Fukuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Fukuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Fukuda. The network helps show where Ryo Fukuda may publish in the future.

Co-authorship network of co-authors of Ryo Fukuda

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Fukuda. A scholar is included among the top collaborators of Ryo Fukuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Fukuda. Ryo Fukuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hepatotoxicity Reduction Profiles of Antisense Oligonucleotides Containing Amido-Bridged Nucleic Acid and 2′-O,4′-C-Spirocyclopropylene Bridged Nucleic Acid 2025 ·Nucleic Acid Therapeutics ·(unknown), Shoji Asano, Hitoshi Kandori, Masami Aoki, (unknown), Kazuo Sekiguchi, Kotaro Yokoyama, Ryo Fukuda, T. Umemoto	2
2	Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages 2025 ·Molecular Cancer ·Ryo Fukuda, Yukio Fujiwara, Hitoshi Maeda, Cheng Pan, (unknown), Hiromu Yano, (unknown), (unknown), Rin Yamada, Yoichi Saito, (unknown), Shuhei Imoto, Keishi Yamasaki, Kentaro Oniki, Junji Saruwatari, Masaki Otagiri, Hiroshi Watanabe, (unknown), Toru Maruyama	1
3	Speech Emotion Recognition Based on Large-Scale Automatic Speech Recognizer 2025 ·Ryo Fukuda, (unknown), (unknown), (unknown)	1
4	NAIST Simultaneous Speech Translation System for IWSLT 2024 2024 ·(unknown), Ryo Fukuda, (unknown), (unknown), (unknown), Kosuke Doi, (unknown), (unknown), (unknown), Sakriani Sakti, Katsuhito Sudoh, Satoshi Nakamura	1
5	NAIST Simultaneous Speech-to-speech Translation System for IWSLT 2023 2023 ·Ryo Fukuda, (unknown), (unknown), (unknown), (unknown), Kosuke Doi, (unknown), Sakriani Sakti, Katsuhito Sudoh, Satoshi Nakamura	2
6	α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages 2021 ·Cancer Research ·(unknown), Yukio Fujiwara, Cheng Pan, Shigeyuki Esumi, Yoichi Saito, Jing Bi, Yuka Nakamura, (unknown), Toru Takeo, Naomi Nakagata, Daiki Yoshii, Ryo Fukuda, (unknown), (unknown), Hisakazu Komori, Hitoshi Maeda, Hiroshi Watanabe, Koji Tamada, Yoshihiro Komohara, Toru Maruyama	21
7	Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway 2020 ·Scientific Reports ·Kazuhiro Murai, Hayato Hikita, Yugo Kai, Yasuteru Kondo, Makoto Fukuoka, (unknown), Akira Doi, Takuo Yamai, Tasuku Nakabori, Ryo Fukuda, Takeshi Takahashi, Kei Miyakawa, Hiroshi Suemizu, Akihide Ryo, Ryoko Yamada, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara	17
8	Energy Management by Enhanced Glycolysis in G1-phase in Human Colon Cancer Cells In Vitro and In Vivo 2013 ·Molecular Cancer Research ·Yan Bao, Kuniaki Mukai, Takako Hishiki, Akiko Kubo, Mitsuyo Ohmura, Yuki Sugiura, Tomomi Matsuura, Yoshiko Nagahata, Noriyo Hayakawa, Takehiro Yamamoto, Ryo Fukuda, Hideyuki Saya, Makoto Suematsu, Yoji Andrew Minamishima	52
9	Interactions of Multiple Gas-Transducing Systems: Hallmarks and Uncertainties of CO, NO, and H ₂ S Gas Biology 2009 ·Antioxidants and Redox Signaling ·Mayumi Kajimura, Ryo Fukuda, Ryon M. Bateman, Takehiro Yamamoto, Makoto Suematsu	226
10	HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells breakdown → 2007 ·Cell ·Ryo Fukuda, Huafeng Zhang, Jung‐whan Kim, Larissa A. Shimoda, Chi V. Dang, Gregg L. Semenza	967
11	9-cis Retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor 2003 ·Journal of Laboratory and Clinical Medicine ·Sachiko Hamamoto, Ryo Fukuda, Norihisa Ishimura, M.A.K. Rumi, Hideaki Kazumori, Yasushi Uchida, Yasunori Kadowaki, Shunji Ishihara, Yoshikazu Kinoshita	27
12	New behavioral mutant rat exhibiting circling behavior (clx) controlled by a sex‐linked recessive gene 2002 ·Congenital Anomalies ·(unknown), Ryo Fukuda, (unknown), Yojiro Ooshima	3
13	Adherence of Helicobacter pylori to gastric epithelial cells and mucosal inflammation 2002 ·Journal of Laboratory and Clinical Medicine ·(unknown), Shunji Ishihara, (unknown), (unknown), Hiroshi Endô, Ryo Fukuda, Kyoichi Adachi, Makoto Watanabe, Masafumi Nαkαo, Yoshikazu Kinoshita	17
14	Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma 2001 ·British Journal of Cancer ·M. A. Karim Rumi, Hiroshi Sato, Shunji Ishihara, Kousaku Kawashima, Sachiko Hamamoto, Hideaki Kazumori, T. Okuyama, Ryo Fukuda, Naofumi Nagasue, Yoshihisa Kinoshita	76
15	Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity 2000 ·The American Journal of Gastroenterology ·Misa Niigaki, Ryo Fukuda, Sachiko Hamamoto, Norihisa Ishimura, Shunji Ishihara, Shuji Akagi, Makoto Watanabe, Yoshikazu Kinoshita	2
16	Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver 1997 ·Journal of Hepatology ·Ryo Fukuda, Norihisa Ishimura, Yoshinori Kushiyama, Nobuyuki Moriyama, Shunji Ishihara, (unknown), Tatsuya Miyake, Misa Niigaki, Shuichi Satoh, (unknown), Shuji Akagi, Makoto Watanabe, Shiro Fukumoto	50
17	Cytokine gene expression in the gastric mucosa: Its role in chronic gastritis 1996 ·Journal of Gastroenterology ·(unknown), Ryo Fukuda, (unknown)	17
18	X Gene and Precore Region Mutations in the Hepatitis B Virus Genome in Persons Positive for Antibody to Hepatitis B e Antigen: Comparison between Asymptomatic "Healthy" Carriers and Patients with Severe Chronic Active Hepatitis 1995 ·The Journal of Infectious Diseases ·Ryo Fukuda, (unknown), Norihisa Ishimura, Shunji Ishihara, (unknown), (unknown), Shuji Akagi, Makoto Watanabe, Seiji Fukumoto	20
19	Precore region mutation in hepatitis B virus genome in early stage of infection: A study in hepatitis B e antigen-positive young carriers 1994 ·Journal of Gastroenterology ·(unknown), Ryo Fukuda, Shiro Fukumoto	7
20	Immunohistochemical study of duck hepatitis B virus in acute infection: Relationship between the distribution of DHBVs ag and the inflammatory changes in the liver. 1989 ·Kanzo ·Ryo Fukuda, (unknown), (unknown), (unknown), Shuji Akagi, (unknown), Yoshihiro Shimada	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact